World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Guo CY, Wu YB, Liu HL, Wu JY, Zhong MZ. Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection. World J Gastroenterol 2004; 10(5): 747-749 [PMID: 14991953 DOI: 10.3748/wjg.v10.i5.747]
URL:	https://www.wjgnet.com/1007-9327/full/v10/i5/747.htm

(0) (0) (0) (4353) (25)

Number	Citing Articles
1	Samson Cantu, Mark A. Gilger. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2009; doi: 10.1016/B978-1-4160-4044-6.50152-7
2	György M Buzás, Jolán Józan. Nitrofuran‐based regimens for the eradication of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2007; 22(10) doi: 10.1111/j.1440-1746.2007.05082.x
3	Chao-ran Ji, Jing Liu, Yue-yue Li, Chuan-guo Guo, Jun-yan Qu, Yan Zhang, Xiuli Zuo. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis. BMJ Open 2020; 10(10) doi: 10.1136/bmjopen-2020-037375
4	Faezeh Kiani, Sara Khademolhosseini, Jasem Mohammadi, Arian Tavasol, Ramtin Hajibeygi, Mobina Fathi, Majid Dousti. Novel Information Regarding the Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Current Reviews in Clinical and Experimental Pharmacology 2024; 19(2) doi: 10.2174/2772432818666230120111237
5	Quan Zhou, Ling-Ling Zhu, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Drug utilization of clarithromycin for gastrointestinal disease treatment. World Journal of Gastroenterology 2008; 14(39): 6065-6071 doi: 10.3748/wjg.14.6065 Abstract(1250) \| Core Tip(1056) \| Full Article(HTML)(3235) \| Full Article (PDF)-762K(475) \| Times Cited (3) \| Total Visits (4161) \| Open
6	Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li. Application of furazolidone in Helicobacter pylori infection eradication. Journal of Digestive Diseases 2024; 25(3) doi: 10.1111/1751-2980.13265
7	Eva C. Arrua, Sofía V. Sanchez, Valeria Trincado, Antonio Hidalgo, Andrew F.G. Quest, Javier O. Morales. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori. Colloids and Surfaces B: Biointerfaces 2022; 213 doi: 10.1016/j.colsurfb.2022.112403
8	Liya Zhuge, Youhua Wang, Shuang Wu, Ru‐Lin Zhao, Zhen Li, Yong Xie. Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta‐analysis. Helicobacter 2018; 23(2) doi: 10.1111/hel.12468
9	A. A. NIJEVITCH, P. L. SHCHERBAKOV, V. U. SATAEV, R. SH. KHASANOV, R. AL KHASHASH, M. M. TUYGUNOV. Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. Alimentary Pharmacology & Therapeutics 2005; 22(9) doi: 10.1111/j.1365-2036.2005.02656.x
10	Angelo Zullo, Cesare Hassan, Salvatore MA Campo, Sergio Morini. Evolving therapy for Helicobacter pylori infection. Expert Opinion on Therapeutic Patents 2004; 14(10) doi: 10.1517/13543776.14.10.1453
11	Wei-Wen Huang, Jiang Lin. A systematic review of treating <italic>Helicobacter pylori</italic> infection with Traditional Chinese Medicine. World Journal of Gastroenterology 2009; 15(37): 4715-4719 doi: 10.3748/wjg.15.4715 Abstract(1527) \| Core Tip(986) \| Full Article(HTML)(4934) \| Full Article (PDF)-701K(2440) \| Times Cited (26) \| Total Visits (8431) \| Open
12	S. Turi, D. Schilling, J. F. Riemann. Eradikation und chronische S�ureblockade. Der Internist 2004; 45(11) doi: 10.1007/s00108-004-1237-0
13	Ying-Qun Zhou, Ling Xu, Bing-Fang Wang, Xiao-Ming Fan, Jian-Ye Wu, Chun-Yan Wang, Chuan-Yong Guo, Xuan-Fu Xu. Modified Sequential Therapy Regimen versus Conventional Triple Therapy forHelicobacter pyloriEradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study. Gastroenterology Research and Practice 2012; 2012 doi: 10.1155/2012/405425
14	Tao Wu, Lichen Wang, Meiliang Gong, Yunjuan Lin, Yaping Xu, Ling Ye, Xiang Yu, Jing Liu, Jianwei Liu, Shuli He, Hao Zeng, Gangshi Wang. Synergistic effects of nanoparticle heating and amoxicillin on H. pylori inhibition. Journal of Magnetism and Magnetic Materials 2019; 485 doi: 10.1016/j.jmmm.2019.04.076
15	Faezeh Kiani, Sara Khademolhosseini, Mobina Fathi, Arian Tavasol, Jasem Mohammadi, Majid Dousti, Jalal Eshagh Hoseini. Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Current Reviews in Clinical and Experimental Pharmacology 2023; 18(2) doi: 10.2174/2772432817666220317152544
16	Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie, Xiao-Jiang Zhou. Standard triple therapy for <italic>Helicobacter pylori</italic> infection in China: A meta-analysis. World Journal of Gastroenterology 2014; 20(40): 14973-14985 doi: 10.3748/wjg.v20.i40.14973 Abstract(1458) \| Core Tip(1362) \| Full Article(HTML)(7084) \| Full Article (PDF)-1135K(705) \| Full Article (Word)-728K(360) \| Peer-Review Report-88K(333) \| Answering Reviewers-112K(338) \| Times Cited (39) \| Total Visits (9226) \| Open
17	Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology. 2010; doi: 10.1002/9781444314403.ch6
18	Yong Xie, Zhenyu Zhang, Junbo Hong, Wenzhong Liu, Hong Lu, Yiqi Du, Weihong Wang, Jianming Xu, Xuehong Wang, Lijuan Huo, Guiying Zhang, Chunhui Lan, Xiaoyan Li, Yanqing Li, Hong Wang, Guoxin Zhang, Yin Zhu, Xu Shu, Ye Chen, Jiangbin Wang, Nonghua Lu. Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China. Helicobacter 2018; 23(5) doi: 10.1111/hel.12496
19	Fernando M Silva, Jaime N Eisig, Ana Cristina S Teixeira, Ricardo C Barbuti, Tomás Navarro-Rodriguez, Rejane Mattar. Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy. BMC Gastroenterology 2008; 8(1) doi: 10.1186/1471-230X-8-20
20	Min Luo, Yi-Yang Jia, Zi-Wei Jing, Chen Li, Si-Yuan Zhou, Qi-Bing Mei, Bang-Le Zhang. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori. Colloids and Surfaces B: Biointerfaces 2018; 164 doi: 10.1016/j.colsurfb.2018.01.008
21	John V. Williams. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2025; doi: 10.1016/B978-0-323-82763-8.00135-7
22	Yu-Hsin Lin, Jui-Hsiang Lin, Shen-Chieh Chou, Shu-Jen Chang, Chun-Chia Chung, Yueh-Sheng Chen, Chiung-Hung Chang. Berberine-Loaded Targeted Nanoparticles as SpecificHelicobacter PyloriEradication Therapy:In VitroandIn VivoStudy. Nanomedicine 2015; 10(1) doi: 10.2217/nnm.14.76
23	Conghua Song, Xing Qian, Yin Zhu, Xu Shu, Yanping Song, Zhijuan Xiong, Jianfang Ye, Tao Yu, Ling Ding, Hui Wang, Nonghua Lu, Yong Xie. Effectiveness and safety of furazolidone‐containing quadruple regimens in patients with Helicobacter pylori infection in real‐world practice. Helicobacter 2019; 24(4) doi: 10.1111/hel.12591
24	Karin Van Amsterdam, Arnoud H. M. Van Vliet, Johannes G. Kusters, Arie Van Der Ende. Of microbe and man: determinants ofHelicobacter pylori-related diseases. FEMS Microbiology Reviews 2006; 30(1) doi: 10.1111/j.1574-6976.2005.00006.x
25	Johannes G. Kusters, Arnoud H. M. van Vliet, Ernst J. Kuipers. Pathogenesis ofHelicobacter pyloriInfection. Clinical Microbiology Reviews 2006; 19(3) doi: 10.1128/CMR.00054-05